Roivant Sciences Ltd.

Pharmaceutical Preparations | SIC: 2834
Phone: 441-295-5950
CIK: 0001635088
EIN: 981173944
State of Inc.: D0
Tickers:
  • Nasdaq:ROIV

Form: 4

Filing Date: 12 Sep 2025
Report Date: 10 Sep 2025
Accepted: 12 Sep 2025 11:00 p.m.
Accession Number: 0001140361-25-034929
Act: None
File Number: None
Film Number: None

Documents

Primary Document: FORM 4
Accepted: 12 Sep 2025 11:00 p.m.